Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
NIH study findings could point toward more effective treatments that could potentially prevent cancer relapse.
Study results help explain why some cancers have different prognosis in men and women, and also suggest novel treatment strategies.
Men who most closely followed the Mediterranean diet had a lower risk of progression.
Men with low-grade prostate cancer are less likely to need treatment if they adhere to the vegetable-rich Mediterranean diet.
While disease progression was higher in Black men, their rates of metastasis and mortality were similar to those of white men.
Among patients with high tumor PD-L1 expression, Libtayo lowered mortality by 43%.
Keytruda plus chemotherapy reduced the risk of disease progression or death by 35% compared with chemotherapy alone in certain people.
Several studies show how COVID-19 affects people with cancers based on their cancer type, disease stage and mode of treatment.
Tucatinib fights breast cancer that spreads to the brain
Lung cancer advocate Don Stranathan takes on the No. 1 cancer killer.
Investigators say their findings support annual blood tests for all individuals with MGUS.
There are now five targeted therapies for the most common type of liver cancer.
ORR, PFS, TTP…we help you sort out what they mean.
The findings lay the groundwork for tests that can identify whether the disease is likely to progress rapidly.
In our brain-tumor community, each of us spend countless hours wondering what we will do when we receive news of a “bad scan.”
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.